FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894852767> ?p ?o ?g. }

• W2894852767 abstract "Abstract Background The objective of this study was to investigate the impact of sodium glucose cotransporter type 2 (SGLT2) inhibitors on left ventricular (LV) diastolic function of type 2 diabetes mellitus (T2DM) patients with heart failure (HF). Methods This trial was a prospective multicenter study of 58 T2DM patients with stable HF at five institutions in Japan. Patients who had been taking at least one antidiabetic drugs other than SGLT2 inhibitors started the administration of 5 mg/day of dapagliflozin. The physical examinations, blood tests, and echocardiography were performed at baseline and 6 months after administration of dapagliflozin. The primary endpoint was defined as a change in mitral inflow E and mitral e′ annular velocities (E/e′) between baseline and 6 months after the administration of dapagliflozin. The secondary end points consisted of a change in brain natriuretic peptide (BNP), LV mass index (LVMI) and left atrial volume index (LAVI). Results E/e′ significantly decreased from 9.3 to 8.5 cm/s (p = 0.020) 6 months after administration of dapagliflozin. LAVI and LVMI significantly decreased from 31 to 26 mL/m 2 (p = 0.001), and from 75.0 to 67.0 g/m 2 (p < 0.001), respectively, 6 months after administration of dapagliflozin. No significant change was observed in BNP (from 27.9 to 28.9 pg/mL; p = 0.132) 6 months after administration of dapagliflozin, except for a significant decrease from 168.8 to 114.3 pg/mL (p = 0.012) in patients with BNP ≥ 100 pg/mL. Conclusion This prospective multicenter trial showed the beneficial effect of SGLT2 inhibitors on LV diastolic functional parameters for T2DM patients with HF. Our findings may thus offer a new insight into the management of T2DM patients. Trial registration UMIN000019789, Registered 28 September 2014, Date of registration: 11/14/2015, Date of enrolment of the first participant to the trial: 6/15/2016, Date of enrolment of the last participant to the trial: 12/9/2017" @default.
• W2894852767 created "2018-10-12" @default.
• W2894852767 creator A5013215849 @default.
• W2894852767 creator A5013313026 @default.
• W2894852767 creator A5017673540 @default.
• W2894852767 creator A5026845589 @default.
• W2894852767 creator A5032646427 @default.
• W2894852767 creator A5057778040 @default.
• W2894852767 creator A5068690527 @default.
• W2894852767 creator A5075305875 @default.
• W2894852767 creator A5081096713 @default.
• W2894852767 creator A5082343515 @default.
• W2894852767 creator A5090187727 @default.
• W2894852767 date "2018-10-08" @default.
• W2894852767 modified "2023-10-18" @default.
• W2894852767 title "Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure" @default.
• W2894852767 cites W122121821 @default.
• W2894852767 cites W136210392 @default.
• W2894852767 cites W177304574 @default.
• W2894852767 cites W1983442180 @default.
• W2894852767 cites W2028488250 @default.
• W2894852767 cites W2036127635 @default.
• W2894852767 cites W2042293234 @default.
• W2894852767 cites W2048199961 @default.
• W2894852767 cites W2054005523 @default.
• W2894852767 cites W2072203364 @default.
• W2894852767 cites W2100166328 @default.
• W2894852767 cites W2101344933 @default.
• W2894852767 cites W2124624517 @default.
• W2894852767 cites W2129094446 @default.
• W2894852767 cites W2146264128 @default.
• W2894852767 cites W2165048419 @default.
• W2894852767 cites W2171471305 @default.
• W2894852767 cites W2187526770 @default.
• W2894852767 cites W2427094903 @default.
• W2894852767 cites W2523805939 @default.
• W2894852767 cites W2557156634 @default.
• W2894852767 cites W2572657306 @default.
• W2894852767 cites W2580433131 @default.
• W2894852767 cites W2607335081 @default.
• W2894852767 cites W2626446274 @default.
• W2894852767 cites W2765097799 @default.
• W2894852767 cites W2790193266 @default.
• W2894852767 cites W2793722678 @default.
• W2894852767 cites W2806818105 @default.
• W2894852767 cites W4252437054 @default.
• W2894852767 cites W962524464 @default.
• W2894852767 doi "https://doi.org/10.1186/s12933-018-0775-z" @default.
• W2894852767 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6174555" @default.
• W2894852767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30296931" @default.
• W2894852767 hasPublicationYear "2018" @default.
• W2894852767 type Work @default.
• W2894852767 sameAs 2894852767 @default.
• W2894852767 citedByCount "119" @default.
• W2894852767 countsByYear W28948527672018 @default.
• W2894852767 countsByYear W28948527672019 @default.
• W2894852767 countsByYear W28948527672020 @default.
• W2894852767 countsByYear W28948527672021 @default.
• W2894852767 countsByYear W28948527672022 @default.
• W2894852767 countsByYear W28948527672023 @default.
• W2894852767 crossrefType "journal-article" @default.
• W2894852767 hasAuthorship W2894852767A5013215849 @default.
• W2894852767 hasAuthorship W2894852767A5013313026 @default.
• W2894852767 hasAuthorship W2894852767A5017673540 @default.
• W2894852767 hasAuthorship W2894852767A5026845589 @default.
• W2894852767 hasAuthorship W2894852767A5032646427 @default.
• W2894852767 hasAuthorship W2894852767A5057778040 @default.
• W2894852767 hasAuthorship W2894852767A5068690527 @default.
• W2894852767 hasAuthorship W2894852767A5075305875 @default.
• W2894852767 hasAuthorship W2894852767A5081096713 @default.
• W2894852767 hasAuthorship W2894852767A5082343515 @default.
• W2894852767 hasAuthorship W2894852767A5090187727 @default.
• W2894852767 hasBestOaLocation W28948527671 @default.
• W2894852767 hasConcept C126322002 @default.
• W2894852767 hasConcept C134018914 @default.
• W2894852767 hasConcept C164705383 @default.
• W2894852767 hasConcept C203092338 @default.
• W2894852767 hasConcept C2775915353 @default.
• W2894852767 hasConcept C2777422806 @default.
• W2894852767 hasConcept C2778198053 @default.
• W2894852767 hasConcept C2910068830 @default.
• W2894852767 hasConcept C535046627 @default.
• W2894852767 hasConcept C555175668 @default.
• W2894852767 hasConcept C555293320 @default.
• W2894852767 hasConcept C57900726 @default.
• W2894852767 hasConcept C71924100 @default.
• W2894852767 hasConcept C84393581 @default.
• W2894852767 hasConceptScore W2894852767C126322002 @default.
• W2894852767 hasConceptScore W2894852767C134018914 @default.
• W2894852767 hasConceptScore W2894852767C164705383 @default.
• W2894852767 hasConceptScore W2894852767C203092338 @default.
• W2894852767 hasConceptScore W2894852767C2775915353 @default.
• W2894852767 hasConceptScore W2894852767C2777422806 @default.
• W2894852767 hasConceptScore W2894852767C2778198053 @default.
• W2894852767 hasConceptScore W2894852767C2910068830 @default.
• W2894852767 hasConceptScore W2894852767C535046627 @default.
• W2894852767 hasConceptScore W2894852767C555175668 @default.
• W2894852767 hasConceptScore W2894852767C555293320 @default.
• W2894852767 hasConceptScore W2894852767C57900726 @default.
• W2894852767 hasConceptScore W2894852767C71924100 @default.

• next